Cancer Program Should Get $2 Billion A Year, Amos Says; “Feds Short On Money, Long of Regs”: Yarbro
In Brief: ACS Considers Expanding Psychosocial Program, Taylor Says; Mendelsohn, Pitot Join NTP Board
Cooperative Groups With Cancer Control Contracts Receive Two Year Renewals
NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity
Pancreatic Lesions Related To Corn Oil Status Reports Made
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation